We measured viral infectivity at the highest IFN dose and expressed this residual infection (Vres) as a percentage of the viral infectivity in the absence of IFN for both IFN-α2a and IFN-β for every virus (Fig. 8a and b). This evidence concerns the gene IFNB1 and infection.